7月2日 - ** Canaccord Genuity给予虚拟医疗服务提供商Omada Health OMDA.O"买入 "评级
** 券商称，OMDA的人工智能虚拟医疗平台能让患者在就医间隙保持参与并改善疗效，使其在竞争激烈的慢性病医疗市场中脱颖而出
** 券商将目标价定为27美元，较上一交易日收盘价上涨47.9%。
** 截至上次收盘，该公司股票较 6 月份首次公开募股（(link)）时 19 美元的发行价下跌了 3.9
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.